The J. Craig Venter Institute got a loan worth more than $2 million, while neurodegeneration-focused startup Yumanity Therapeutics got more than $1 million.
Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings together all the units ...
Short reports are nothing new, but the aggressive “I’m coming after you” PR from Applied Therapeutics certainly is.
Despite the turmoil of an ongoing pandemic, global venture funding for the second quarter of 2020 was not as dire as we expected, but it was down from previous years.
Pfizer is deepening its already long-term investment and partnership strategy with U.K.-based biotech Mission Therapeutics and its work on selectively inhibiting deubiquitylating enzymes.
Repurpose.AI landed a deal with drug maker LEO Pharma to identify possible candidates for dermatology and inflammatory conditions.
The same week Annexon Biosciences announced it had raised $100 million in private financing to advance its research of antibody drugs to treat